A novel tumor suppressor, BATF2, can be silenced by factors in the tumor microenvironment, leading to a reduced immune ...

Cancer cells survive therapy by dynamically rewiring their metabolism in response to nutrient availability, ...

Researchers found in mice that multiple nutrients and cancer cell characteristics work together to control the spread of ...

The field of cancer immunology has witnessed dramatic progress with the advent of immunotherapies targeting the tumor immune microenvironment (TIME).

Cleveland Clinic researchers have discovered that bacteria inside cancerous tumors may be key to understanding why ...

BATF2 is a new type of tumor suppressor that can be epigenetically silenced by high levels of glutamine in the tumor microenvironment Glutamine silences BATF2 and leads to a weakened immune response ...

In recent years, cancer immunotherapy has transformed the treatment landscape for a wide range of malignancies, offering ...

A large-scale international study, led by researchers from the Gray Faculty of Medical and Health Sciences at Tel Aviv ...